Vijaya Diagnostic Centre Ltd
Press Release on Q1 Un-audited financial results for FY 27
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 06 Aug 2026, 09:41 PM IST · BSE ID: baf8adb9-6c7c-4f1d-be68-0a50e538d4f9
View Original BSE Filing (PDF)
💡
In Simple Terms
The diagnostic company reported higher quarterly profits and revenues, expanding its testing centers and services.
🤖 AI Summary
- Profit after Tax (PAT) for Q1 FY27 increased 37.6% YoY to 531.0 Rs. Mn.
- Revenue from Operations for Q1 FY27 rose 22.8% YoY to 2,309.8 Rs. Mn.
- EBITDA for Q1 FY27 grew 34.0% YoY to 985.4 Rs. Mn, with a 42.7% margin.
- The company commissioned a flagship hub centre in Bengaluru and 4 new spokes during Q1 FY27.
- Total Tests increased 16.5% YoY to 4.59 million, and Total Footfall rose 12.7% YoY to 1.24 million.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from Operations (Q1 FY27)
2,309.8 Rs. Mn
22.8%
EBITDA (Q1 FY27)
985.4 Rs. Mn
34.0%
Profit after Tax (PAT) (Q1 FY27)
531.0 Rs. Mn
37.6%
Total Tests (Q1 FY27)
4.59 million
16.5%
Total Footfall (Q1 FY27)
1.24 million
12.7%
Avg realization per test (Q1 FY27)
503 Rs
5.5%
🏢 How This Affects the Company
The company's revenue growth, driven by increased test volumes and footfall, suggests an expanded market reach and service utilization. Strategic network expansion into core geographies, including Bengaluru, enhances its competitive positioning.
Improved EBITDA and PAT margins indicate enhanced operational efficiency and profitability. The increase in average realization per test and per footfall directly contributes to higher revenue and bottom-line growth.
Commissioning new hub and spoke centers in Hyderabad, Bengaluru, AP, and Pune expands the company's operational footprint and capacity. This expansion supports volume growth and the introduction of advanced imaging technologies like the wide Bore 3T Omega MRI.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results press release.
👤
Who Is Affected
Shareholders are provided with updated financial performance data, including Q1 FY27 revenue, profit, and operational metrics.
🔍
Management Signal
Management is focused on delivering revenue growth through volume expansion and strategic network build-out in core geographies.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 results — monitor continuation of revenue and profit growth.
Updates on network expansion — observe commissioning of new centers.
Management commentary on market share in new geographies.
LOW RISK
The filing indicates positive financial and operational performance with no flagged risks.
💡 Investor Takeaway
Vijaya Diagnostic Centre reported Q1 FY27 Profit after Tax of 531.0 Rs. Mn, up 37.6% YoY, and Revenue from Operations of 2,309.8 Rs. Mn, a 22.8% YoY increase. EBITDA reached 985.4 Rs. Mn, growing 34.0% YoY, alongside strategic network expansion.
⚖️ Strengths & Concerns
✅ Positives
- Q1 FY27 Profit after Tax (PAT) increased by 37.6% YoY to 531.0 Rs. Mn, demonstrating strong profitability growth.
- Revenue from Operations grew by 22.8% YoY to 2,309.8 Rs. Mn, supported by a 16.5% increase in Total Tests.
📅 Company Track Record
Vijaya Diagnostic Centre reported Q1 FY27 Net Profit After Tax of Rs. 53,147.6 Lakh, building on prior year's performance. The company’s Board meeting was scheduled for August 06, 2026, to approve these un-audited financial results for Q1 FY27.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Vijaya Diagnostic Centre's Profit after Tax in Q1 FY27?
Vijaya Diagnostic Centre reported a Profit after Tax (PAT) of 531.0 Rs. Mn for Q1 FY27, an increase of 37.6% compared to Q1 FY26.
What was Vijaya Diagnostic Centre's Revenue from Operations in Q1 FY27?
Revenue from Operations for Vijaya Diagnostic Centre in Q1 FY27 was 2,309.8 Rs. Mn, showing a 22.8% year-on-year growth from Q1 FY26.
What was Vijaya Diagnostic Centre's EBITDA in Q1 FY27?
Vijaya Diagnostic Centre's EBITDA for Q1 FY27 stood at 985.4 Rs. Mn, which is a 34.0% increase over Q1 FY26.
How many total tests did Vijaya Diagnostic Centre conduct in Q1 FY27?
Vijaya Diagnostic Centre conducted 4.59 million total tests in Q1 FY27, representing a 16.5% increase from Q1 FY26.
What new centers did Vijaya Diagnostic Centre commission in Q1 FY27?
In Q1 FY27, Vijaya Diagnostic Centre commissioned a hub centre in Gachibowli, Hyderabad, and its flagship hub centre in Bengaluru at JP Nagar. Additionally, 4 spokes were commissioned across Hyderabad, AP, and Pune.
Questions based on this BSE filing only. For information purposes.